`

Cyprotex

Research Services

Specialities :
In vitro adme
In vitro toxicology
Transporters
Cardiotoxicity
Dmpk

+3

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$2.68M
size-icon Size
201 - 500
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Cyprotex

What does Cyprotex do?+

Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology

What are Cyprotex's specialties? +

In vitro adme,in vitro toxicology,transporters,cardiotoxicity,dmpk,hepatotoxicity,ddi,and neurotoxicity

What is Cyprotex's industry? +

Cyprotex operates in the Research services industry.

What is Cyprotex's revenue? +

Cyprotex's revenue is 11m - 100m

What is Cyprotex's company size? +

Cyprotex has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free